Shaorong Yu

1.8k total citations
52 papers, 1.4k citations indexed

About

Shaorong Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shaorong Yu has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 26 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in Shaorong Yu's work include MicroRNA in disease regulation (15 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer-related molecular mechanisms research (11 papers). Shaorong Yu is often cited by papers focused on MicroRNA in disease regulation (15 papers), Lung Cancer Treatments and Mutations (14 papers) and Cancer-related molecular mechanisms research (11 papers). Shaorong Yu collaborates with scholars based in China and United States. Shaorong Yu's co-authors include Jifeng Feng, Bo Shen, Haixia Cao, Xiaobing Qin, Xiaoyue Xu, Meiqi Shi, Jian Wu, Yong Hu, Leilei Zhou and Dali Yan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shaorong Yu

49 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaorong Yu China 20 1.1k 912 313 231 115 52 1.4k
Satoko Takizawa Japan 21 1.2k 1.2× 1.2k 1.4× 196 0.6× 196 0.8× 94 0.8× 36 1.7k
Elizabeth Pan United States 9 1.5k 1.4× 1.4k 1.5× 331 1.1× 150 0.6× 70 0.6× 24 1.9k
Teresa Bernadette Steinbichler Austria 17 818 0.8× 592 0.6× 437 1.4× 222 1.0× 110 1.0× 46 1.4k
Xiao-Liang Lan China 9 1.6k 1.5× 1.3k 1.5× 342 1.1× 138 0.6× 182 1.6× 16 1.9k
Kundong Zhang China 14 1.0k 0.9× 767 0.8× 292 0.9× 122 0.5× 352 3.1× 20 1.3k
Yuki Takano Japan 18 1.3k 1.2× 1.1k 1.2× 257 0.8× 142 0.6× 111 1.0× 52 1.6k
Ju‐Yeon Jeong South Korea 20 714 0.7× 557 0.6× 384 1.2× 263 1.1× 105 0.9× 31 1.1k
Fatemeh Molaei Iran 7 1.3k 1.2× 864 0.9× 126 0.4× 113 0.5× 191 1.7× 9 1.4k
Kentaro Jingushi Japan 19 930 0.9× 616 0.7× 154 0.5× 151 0.7× 88 0.8× 45 1.1k
Kang Shao China 21 841 0.8× 660 0.7× 302 1.0× 277 1.2× 109 0.9× 57 1.3k

Countries citing papers authored by Shaorong Yu

Since Specialization
Citations

This map shows the geographic impact of Shaorong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaorong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaorong Yu more than expected).

Fields of papers citing papers by Shaorong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaorong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaorong Yu. The network helps show where Shaorong Yu may publish in the future.

Co-authorship network of co-authors of Shaorong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaorong Yu. A scholar is included among the top collaborators of Shaorong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaorong Yu. Shaorong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Min, Wenhui Zhao, Ting Qian, et al.. (2024). CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5. Cellular Signalling. 122. 111341–111341.
2.
Yu, Shaorong, et al.. (2024). A hybrid unsupervised learning approach for noise removal in particle image velocimetry. Physics of Fluids. 36(11). 1 indexed citations
3.
Huang, Xing, Yutao Li, Xiaochen Huang, et al.. (2023). A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma. International Immunopharmacology. 127. 111286–111286. 5 indexed citations
4.
5.
Huang, Xing, Shaorong Yu, Bo Shen, et al.. (2022). A Prognostic Risk Model of a Novel Oxidative Stress‐Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma. Oxidative Medicine and Cellular Longevity. 2022(1). 2262014–2262014. 6 indexed citations
6.
7.
8.
Qian, Ting, Hui Zhang, Shaorong Yu, et al.. (2021). Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion. Journal of Thoracic Disease. 13(5). 3061–3069. 3 indexed citations
9.
Chen, Yan, et al.. (2020). B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma. Pathology - Research and Practice. 216(10). 153134–153134. 27 indexed citations
10.
Yu, Shaorong, Huanhuan Sha, Xiaobing Qin, et al.. (2020). EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells. Oncogene. 39(13). 2643–2657. 55 indexed citations
11.
12.
Xu, Xiaoyue, Leilei Zhou, Yu Chen, et al.. (2018). Advances of circular RNAs in carcinoma. Biomedicine & Pharmacotherapy. 107. 59–71. 20 indexed citations
13.
Yu, Shaorong, Wenbo Sun, Xiaobing Qin, et al.. (2017). MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment. Journal of Cancer Research and Clinical Oncology. 144(3). 431–438. 10 indexed citations
14.
Shi, Meiqi, Jing Sun, Jinsong Zhou, et al.. (2017). Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies. Investigational New Drugs. 36(2). 269–277. 17 indexed citations
15.
Shen, Bo, Shaorong Yu, Yan Zhang, et al.. (2016). miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway. OncoTargets and Therapy. Volume 9. 6009–6019. 54 indexed citations
16.
Wu, Ying, Dandan Yu, Yong Hu, et al.. (2016). Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray. Oncology Reports. 35(6). 3371–3386. 19 indexed citations
17.
Hu, Yong, Xiaobing Qin, Haixia Cao, Shaorong Yu, & Jifeng Feng. (2016). Reversal effects of local anesthetics on P-glycoprotein-mediated cancer multidrug resistance. Anti-Cancer Drugs. 28(3). 243–249. 11 indexed citations
18.
Wu, Ying, Dandan Yu, Yong Hu, et al.. (2015). LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation. Biochemical and Biophysical Research Communications. 467(4). 900–905. 17 indexed citations
19.
Yu, Shaorong, et al.. (2012). Modified PNA-PCR method. Cancer Biology & Therapy. 13(5). 314–320. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoko Takizawa Breakdown of academic impact, for papers by Elizabeth Pan Breakdown of academic impact, for papers by Teresa Bernadette Steinbichler Breakdown of academic impact, for papers by Xiao-Liang Lan Breakdown of academic impact, for papers by Kundong Zhang Breakdown of academic impact, for papers by Yuki Takano Breakdown of academic impact, for papers by Ju‐Yeon Jeong Breakdown of academic impact, for papers by Fatemeh Molaei Breakdown of academic impact, for papers by Kentaro Jingushi Breakdown of academic impact, for papers by Kang Shao
Rankless by CCL
2026